Diverticulitis Disease Market 2025-2034: Key Highlights, Growth Dynamics, and Emerging Trends
2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!
How Are Key Drivers in the Industry Acting as Catalysts for the Growth of theDiverticulitis Disease Market?
The growth of the diverticulitis disease market is projected to be fuelled by the escalating instances of smoking addiction. This increasing addiction is due to the aggressive marketing tactics, social acceptability of smoking, stress, and the highly addictive nature of nicotine. Young generations are also falling prey to this epidemic due to the popularity of e-cigarettes, vape devices, and peer pressure. Smoking amplifies the risk of diverticular disease by weakening the blood circulation to the colon, leading to more severe consequences and subsequently demand for medical intervention. For example, Statistics Canada reported in July 2022 that cigarette production had upped 5.8% from June 2021, with the total number of sold cigarettes increasing by 1.3% from May 2022, totaling 1.4 billion in June 2022. Thus, the growing smoking addiction will undoubtedly promote the development of the diverticulitis disease market. The escalation in instances of diabetes is another crucial contributor to the advancement of the diverticulitis disease market. Unhealthy consumption habits, increasing obesity rates, genetic factors, a sedentary lifestyle, and an aging population primarily fuel diabetes. Diabetes facilitates the rise in risks associated with diverticulitis treatment such as a weak vascular system that make the colon more vulnerable to inflammations and infections, hence enhancing the demand for treatments. Case in point, the National Health Service (NHS England) reported in June 2024 that the number of individuals diagnosed with pre-diabetes in England escalated by 18%, from 3,065,825 in 2022 to 3,615,330 in 2023. Moreover, the number of cases soared by nearly 25% in people under 40, from 173,166 in 2022 to 216,440 in 2023. Hence, the rising instances of diabetes fuel the growth of the market for diverticulitis disease.
Get Your Free Sample Report Now – Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12990&type=smp
What is the Predicted Annual Growth Rate of theDiverticulitis Disease Market Impact Industry Trends by 2034?
The market size of diverticulitis disease has seen a swift expansion in recent years. The growth is projected to increase from $1.85 billion in 2024 to $2.04 billion in 2025, with a compound annual growth rate (CAGR) of 10.1%. Factors contributing to the growth in the historic period include an aging population, changes in eating habits, rising obesity rates, and advancements in medical imaging technologies.
The market size for diverticulitis disease is predicted to witness substantial expansion in the upcoming years. The market is projected to escalate to $2.92 billion by 2029, growing at a compound annual growth rate (CAGR) of 9.4%. The enlargement during this period is credited to factors such as colonoscopy and endoscopy, heightened awareness, minimally invasive methodologies, and personalized medicine. The foreseeable future will see trends like precautionary methods, advanced diagnostic apparatus, cooperative care frameworks, and alterations in healthcare policies.
You can Directly Purchase the Report Here:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12990
What Are the Current Market Growth and Trends in theDiverticulitis Disease Market That Industry Players Should Watch?
Leading firms in the diverticulitis disease market are concentrating on innovating and receiving approval for new drugs to maintain their dominance in the industry. This focus on drug invention might lead to the creation of more efficient therapies for diverticulitis, decreasing the chances of complications and enhancing patient recovery. For instance, in April 2023, the United States Food and Drug Administration, a federal organization based in the US, ratified a microbiota drug by Seres designed to treat recurrent gut infections and ward off re-infections of Clostridioides difficile (C. diff.) in adults who are 18 years and above. The approval of Vowst was rooted in a clinical trial that involved 346 patients suffering from recurrent CDI. The trial results showed that patients on Vowst had significantly lower chances of re-infection compared to those on a placebo. The orally-taken drug is composed of microbiota containing Firmicutes spores, known to enhance a healthy microbiome capable of repelling C. diff. colonization.
What Are the Major Market Players Making an Impact on theDiverticulitis Disease Market Growth?
Major companies operating in the diverticulitis disease market are Pfizer Inc., Johnson and Johnson, F. Hoffmann-La Roche AG, Merck & Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca PLC, Abbott Laboratories, GlaxoSmithKline PLC, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Amgen Inc., Viatris Inc., Teva Pharmaceutical Industries Ltd., Astellas Pharma, Eisai Co. Ltd., Sun Pharmaceutical Industries Ltd., Otsuka Pharmaceutical Company, Cipla Limited, Hikma Pharmaceuticals PLC, Endo Pharmaceuticals, Aspen Pharmacare, Zydus Lifesciences, Lupin Limited, Glenmark Pharmaceuticals, Alkem Laboratories, Torrent Pharmaceuticals Ltd.
Order Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/diverticulitis-disease-global-market-report
How Are the Key Segments of the Diverticulitis Disease Market Driving Opportunities and Innovations?
The diverticulitis disease market covered in this report is segmented –
1) By Type: Uncomplicated, Complicated
2) By Diagnosis: Computed Tomography (CT) Scan, Ultrasound, Urine Test, Blood Test
3) By Treatment: Medications, Surgery, Supportive care, Penicillin Antibiotic, Antibiotics, Dietary Supplements, Intravenous (IV) Fluids
4) By End-User: Specialty Centers, Hospitals, Research centers
Subsegments:
1) By Uncomplicated: Outpatient Treatment, Dietary Management, Antibiotic Therapy
2) By Complicated: Hospitalization, Surgical Intervention, Intravenous Antibiotics, Abscess Drainage
Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!
https://www.thebusinessresearchcompany.com/customise?id=12990&type=smp
What Regions Are At the Forefront of #How Are Key Drivers in the Industry Acting as Catalysts for the Growth of theDiverticulitis Disease Market?# Market Expansion?
North America was the largest region in the diverticulitis disease market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in diverticulitis disease market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Browse Through More Reports Similar to the Global Diverticulitis Disease Market 2025, By The Business Research Company:
Digestive Health Supplements Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/digestive-health-supplements-global-market-report
Irritable Bowel Syndrome (IBS) Treatment Global Market Report 2024
Antacids Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/antacids-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on: